The new Class I recall, which includes more than 1.4 million devices, is related to an issue first announced back in 2024. Updating the software should address the issue going forward, though some patients may still require an early replacement.
Using a DCB that releases sirolimus over an extended period of time appears to be both safe and effective when treating patients who present with NSTEMI or unstable angina.
The popular drugs, originally developed to treat diabetes, were also associated with an improved survival rate. Benefits were seen in patients who did and did not lose significant weight as a result of treatment.
However, radiology dropped to 18th on the list of specialists when asked how they feel about their profession’s long-term future, according to new survey data from Medscape.
Published in Clinical Imaging, the responses indicate that Trump administration policies have made it more difficult to acquire funding and collaborate with other researchers.
Like a mirror image on a USA map folded in half vertically, the four best states for nurses are two nextdoor neighbors in the upper Northeast and two in the Pacific Northwest.
The wound and burn gels are manufactured by Integra LifeSciences. Defective packaging could cause the sterile barrier to fail, exposing the gels to pathogens. Due to the risk of severe infections, all recalled products must be removed from where they are used and sold.
As this midterm-election year barrels toward decision day, health insurers continue taking punches from both political parties. The piling-on might be as unfair as it is understandable.
